All Type of News


Pharmas extend rebate control to client distributors

While the pharmaceutical industry has recently had rebate issues once again, individual pharmaceutical companies are tightening their own rules to eradicate rebates. They have only performed a program to eradicate re...

Daewoong Pharmaceutical acquires preferential sale right in KRW 150 billion hepatitis B generic market

Daewoong Pharmaceutical will enter the market of ‘tenofovir,’ a hepatitis B treatment, worth of approximately KRW 150 billion. Daewoong Pharmaceutical(CEO Jong-Wook Lee) announ...

Health and Welfare Committee conducts parliamentary inspections between 12th and 31st of October

Regular parliamentary inspections of the government offices will be conducted between the 12th and 31st of October. Ruling and opposing parties of the National Assembly Health and Welfare Committee agreed to have ins...

Tonymoly gives up acquisition of Tai Guk Pharm, largest dermatologic product company

Tonymoly, a cosmetic brand, gave an official notice to acquire Tai Guk Pharm(decided to acquire 5.826 million shares, KRW 14 billion), the Korea’s largest pharmaceutical company specializing in dermatologic products, ...

MFDS announces 2,020 products applied differentials for small packaging rule

On 13 September, the Ministry of Food and Drug Safety(MFDS) announced 2,020 products which do not follow the differential small-quantity packaging standards for medicines. The announcement indicated 655 products for ...

Seoul Western DPO considers to start clinic S’s rebate investigation

The pharmaceutical field is getting nervous as the Seoul Western District Prosecutor’s Office(Seoul Western DPO), which has been quiet over pharmaceutical companies’ rebates, have shown movements to start a rebate inv...

“They need to understand International Nonproprietary Names is an international trend”

The Korean Pharmaceutical Association(President Chan-Hwi Cho, KPA) criticized the Korean Medical Association’s(KMA) argument about the ‘International Nonproprietary Names(INN)’ program was ‘implausible,’ and gave a cr...

BUKDA criticizes distribution business invested by medical institutes

The Busan, Ulsan & Kyungnam Distribution Association has made a strong criticism over distribution companies invested jointly by medical institutes. The Busan, Ulsan & Kyungnam Distribution Association(President Cheo...

Dongwha Pharm-MSD Korea signs license agreement of antidepressant ‘Remeron’

Dongwha Pharm(CEO Ji-Hoon Sohn) signed a MSD’s exclusive sale and supply agreement of Remeron(generic name: mirtazapine), a MSD’s antidepressant, in Korea on the 8th of September. Remeron, a MSD’s NaSSA(antidepressan...

TissueGene receives a grand for ‘Invossa’ development from U.S. Maryland

TissueGene(CEO Bum-Seop Lee/Woo-Seok Lee) Co-CEO Woo-Seok Lee participated in a reception at Habib House, the U.S. Ambassador to South Korea’s residence in Seoul, hosted by officials the Maryland Department of Commerc...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.